Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach

Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach

Shu-Ting Pan,1,* Zhi-Wei Zhou,2,3,* Zhi-Xu He,3 Xueji Zhang,4 Tianxin Yang,5 Yin-Xue Yang,6 Dong Wang,7 Jia-Xuan Qiu,1 Shu-Feng Zhou2 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China; 2Depart...

Full description

Bibliographic Details
Main Authors: Pan ST, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/proteomic-response-to-56-dimethylxanthenone-4-acetic-acid-dmxaa-vadime-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/proteomic-response-to-56-dimethylxanthenone-4-acetic-acid-dmxaa-vadime-peer-reviewed-article-DDDT

Similar Items